Journal of Bacteriology, October 2000, p. 5893-5897, Vol. 182, No. 20
0021-9193/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Department of Microbiology and Immunology, University of Illinois College of Medicine, Chicago, Illinois 60612-7344
Received 13 April 2000/Accepted 24 July 2000
| |
ABSTRACT |
|---|
|
|
|---|
Mutation and genetic complementation studies suggested that two
chromosomal loci, agr and sar, are involved in
the upregulation of several exotoxin genes and the downregulation of a
number of surface protein genes in a growth phase-dependent manner in
Staphylococcus aureus. We purified recombinant T7-tagged
SarA from Escherichia coli and determined its effect on
transcription from several S. aureus promoters by using
purified RNA polymerase reconstituted with either
A or
B from S. aureus. Of the seven
A-dependent promoters that we tested, SarA repressed
transcription from agrP2, agrP3,
cna, sarP1, and sea promoters and
did not affect sec and znt promoters.
Furthermore, SarA had no effect on transcription from the
B-dependent sarP3 promoter. In vitro
experimental data presented in this report suggest that SarA expression
is autoregulated.
| |
TEXT |
|---|
|
|
|---|
The pathogenicity of Staphylococcus aureus is attributed to the production of numerous extracellular toxins (e.g., hemolysins, enterotoxins, toxic shock syndrome toxins, proteases, and leukocidins) and surface proteins (e.g., protein A, fibronectin binding proteins, and collagen adhesion protein). Mutation and genetic complementation studies have identified two genetic loci, agr (accessory gene regulator) and sar (staphylococcal accessory regulator), that are involved in the regulation of expression of many of the toxin genes at the transcription level (for agr, references 20, 26, and 31, and for sar, references 1, 9, 11, and 17). The agr locus is divergently transcribed into two RNA molecules, called RNAII and RNAIII, from the promoters P2 and P3, respectively. Of the four open reading frames in the RNAII region, AgrA and AgrC have similarity with two-component signal transduction systems (18, 19, 22). Recently, AgrC was located in S. aureus membranes, and it was shown to be autophosphorylated on a histidine residue (22). An octapeptide, which is posttranslationally processed from AgrD presumably by AgrB, is necessary for the phosphorylation of AgrC. RNAIII, as an RNA molecule (517 nucleotides [nt]), upregulates the expression of several extracellular toxin genes at postexponential phase of growth (27-29). However, the agr system downregulates expression of coagulase and some surface proteins, e.g., protein A and fibronectin binding protein, at exponential phase (26, 34, 36). Interestingly, RNAIII also regulates expression of alpha-toxin posttranscriptionally (27).
The sar locus is at least partly involved in the upregulation of transcription from the agrP2 and agrP3 promoters (6, 10). Three overlapping RNAs, terminating at the same site, are transcribed from three distinct promoters (~580-nt sarA from promoter P1, ~840-nt sarC from P3, and ~1,150-nt sarB from P2) in a growth phase-dependent fashion (1). The largest gene product, SarA, is encoded at the 3' region of all the transcripts. SarA has been shown to bind to different promoters, including agrP2, agrP3 (9, 28, 33), the collagen adhesion gene promoter cna (3), sec, spa, hla, and fnb (11). The level of cna transcript in agr+ or agr S. aureus cells was elevated in a sarA background, implying that cna expression is downregulated by SarA in an agr-independent pathway (3).
SarH1, a homolog of SarA, was recently identified on a separate global
regulatory locus on the S. aureus chromosome
(38). Like sarA, sarH1 is transcribed
from both a
A-dependent promoter and a
B-dependent promoter. Both SarA and RNAIII repress
sarH1 expression, and some of the previously reported
effects of sarA and agr on target gene expression
(hla, spa, and ssp) appear to be
mediated by sarH1. The relative concentrations of RNAIII,
SarA, SarH1, and possibly other regulatory factors most likely dictate
target gene expression. A sequence similarity search (using The
Institute for Genomic Research and the University of Oklahoma
databases) resulted in the identification of three more homologs of
SarA. The calculated molecular masses of SarH2 and SarH4 are each 14 kDa, and the amino acid sequences are 35 and 24% identical to SarA,
respectively. SarH3 has the same molecular mass as SarH1. The amino-
and carboxy-terminal halves of both SarH1 and SarH3 have a high degree
of sequence identity with SarA (33 and 30% at the amino and carboxyl
termini, respectively). The sar homologs are located on
separate loci.
We report here that SarA represses transcription from agrP2,
agrP3, cna, sarP1, and sea
promoters in vitro. This negative regulation by SarA is observed on
several selective primary
factor (
A)-dependent
promoters, but not on the alternative
factor
(
B)-dependent promoter sarP3.
The oligonucleotide primers, plasmids, and bacterial strains used in
this study are listed in Table 1. The
restriction enzyme sites at the termini of each primer are underlined.
PCR amplification was carried out using recombinant Pfu DNA
polymerase (Stratagene, La Jolla, Calif.). Plasmid DNA from pALC561 and
S. aureus RN6650 and chromosomal DNA from S. aureus COL were used as templates for the amplification of
sarA, the agrP2-P3 promoter region, and the
cna promoter region, respectively. Reaction conditions were as follows: melting temperature, 96°C (2 min); annealing temperature, 45°C (2 min); and elongation temperature, 72°C (1 min).
|
pET24a(+)-sarA (Table 1) was created by introducing a DNA fragment containing the sarA gene into the BamHI and HindIII sites of pET24a(+). Escherichia coli strain BL21(DE3) (Novagen, Madison, Wis.), harboring pET24a(+)-sarA, was used for overproduction of T7-tagged SarA. The recombinant SarA was purified using a monoclonal T7-tagged affinity column (Novagen).
Binding of SarA to the cna promoter was studied in an
electrophoretic mobility shift assay (EMSA) following a published
protocol (3, 33), with a buffer solution containing 10 mM
Tris-HCl (pH 7.6), 50 mM KCl, 2 mM dithiothreitol, 2 mM EDTA, 0.05%
Triton X-100, and 3.5 nM probe DNA. A 260-bp DNA fragment flanking 80 bp upstream of the cna promoter was PCR amplified using the
cna oligomers listed in Table 1, under the reaction
conditions described above. The DNA fragment was end labeled with
[
-32P]ATP (specific activity, 3,000 Ci
mmol
1; ICN Pharmaceuticals), purified in a Qiagen spin
column, and used as the probe for the EMSA.
In vitro transcription reactions were carried out following our
published protocol (15, 37). RNA polymerase purified from S. aureus was reconstituted with either
A or
B and was used in transcription reactions. Purified
plasmid DNA (uncut) was used as a template in all the transcription
assays described below.
Effect of SarA on binding to and transcription from the
cna promoter.
We first studied the binding of our
recombinant SarA preparation to cna promoter DNA. As shown
in Fig. 1, SarA bound with the
cna promoter region, and this binding was similar to that observed with a recombinant SarA (33). At SarA
concentrations between 3.4 and 17 nM (Fig. 1, lanes 2 to 4), the probe
shifted as a major band on the top and some smearing occurred. However, at higher SarA concentrations, 34 and 68 nM, the probe shifted as a
single major band (lanes 5 and 6). The smearing of the shifted probe
could arise from unsaturated binding of SarA to multiple sites on the
probe (3). The binding of SarA to the cna
promoter was reversed by adding a 25-fold excess of unlabeled probe,
compared to binding in the presence of the labeled probe DNA (lane 7).
|
|
Effect of SarA on several
A-dependent
promoters.
Since SarA binds to the agrP2-P3 promoter
region and the genes transcribed from the agrP2 promoters
play a pivotal role in the autoregulation of the agr operon,
and since RNAIII transcribed from agrP3 regulates a number
of toxin genes, we cloned the agrP2-P3 promoter region into
the plasmid pMP7. The DNA from the recombinant plasmid pMP7-agrP2-P3
(Table 1) was used as a template to determine the effect of SarA on
transcription from the agrP2 and agrP3 promoters (Fig. 3, lanes 9 to 12). pMP7-agrP2-P3
includes up to the +45 sequence of RNAIII and the +90 sequence of RNAII
start site. All the SarA binding sites in the agrP2-P3
promoter region, as reported by different laboratories (9, 28,
33), are present within the cloned sequence. Fusion transcripts
arising from the cloned agr sequence and the sequence
between the cloned agr DNA and the transcription termination
sites in the vector were obtained. In the transcription assays,
transcript from the znt promoter served as a control for
quantification (data not shown). Note that two unrelated RNA bands
migrated just below the transcript derived from the agrP2
promoter (Fig. 3, compare lanes 3 and 4). Contrary to the current
hypothesis that SarA activates transcription from the agr
operon, these results demonstrate that SarA directly inhibits transcription from both the agrP2 and agrP3
promoters. It can be suggested that SarA, together with some
yet-uncharacterized cellular factor(s), activates transcription of the
agr operon. Alternatively, SarA may regulate expression of
one or more factors which activate agr operon expression in
the cell.
|
42) is enough to maintain a
100% level of SEA compared to that in wild-type S. aureus
(4). Since SarA binds to the promoter region (upstream of
the
35 sequence) of sec (11) and deletion of
the sequence 7 bp upstream of the sea promoter region has no
effect on sea transcription in vivo, we tested the effect of
SarA on transcription from the sea and sec
promoters. Plasmid pMJB1167 (Table 1), used as a template for
sec transcription, contains about 300 bp upstream of the
promoter sequence, and pMJB1168, used as the template for
sea transcription, includes sequence up to position
80 of
the sea promoter region. As shown in Fig. 3 (lanes 5 to 8),
expression from the sec promoter is unaffected or marginally
affected by SarA, while expression from the sea promoter is
severely repressed. Thus, it can be concluded that the binding of SarA
upstream of the sec promoter does not affect its
transcription. Recently, SarH1, a homolog of SarA, was shown to bind
with the agrP3 promoter region and the promoter regions of
the spa and ssp genes in vitro but did not affect
transcription from these promoters in vivo (38). Apparently,
promoter binding and transcriptional regulation of SarA may not always
be correlated. The relative binding affinities of RNA polymerase and
SarA to the promoter DNA may be a determining factor in the ultimate
role of SarA on transcription from the different promoters. How SarA represses transcription cannot be explained with currently available data, and further investigation of this aspect should prove interesting.
Autoregulation of sar operon expression.
From in
vitro binding experiments with an uncharacterized 12-kDa protein and
the sarP1 promoter region, Manna et al. (24) suggested that the expression of sarA is autoregulated. This
is in contrast with the conclusion drawn by Blevins et al.
(3) from their mutation and genetic complementation
experiments that SarA is produced constitutively and the DNA upstream
of the sarA gene promoter makes no contribution to the
regulation of SarA production. We previously observed that of the three
sar transcripts, the shortest one, derived from the promoter
P1, is
A dependent while that from the P3 promoter is
dependent on an alternative
factor,
B
(15). It was of interest to determine the effect of SarA on transcription from the sar promoters. The S. aureus core RNA polymerase was reconstituted with either
A or
B (14, 15). Plasmid DNA
containing the entire sar operon was used as the template in
the transcription assays. As shown in Fig.
4, transcription from the
sarP1 promoter was specifically inhibited by SarA (lanes 2 to 4), while SarA had no effect on transcription from the
sarP3 promoter (lanes 5 to 7). We could not detect any
transcript from the sarP2 promoter (Fig. 4; also previously
reported in reference 15), implying that
transcription from this promoter is positively regulated by one or more
unknown factors in the cell.
|
A-dependent sarP1, but it did not
affect transcription from the
B-dependent
sarP3. Most of the genetic studies on the regulation of
toxin gene expression have been carried out using S. aureus strain 8325-4 or its derivatives (RN6390 and RN6390B) as the parent strain. Recently, a naturally occurring 11-bp deletion within the
rsbU gene, encoding anti-anti-
B factor, in
S. aureus strain 8325-4 was reported (21). Most likely, this mutation severely affects cellular levels of active
B (25). Note that the synthesis of
hla mRNA in derivatives of S. aureus 8325-4 and
in strain V8, which lacks RNAIII, was significantly repressed
(27). The hla mRNA level was undetectable in the
S. aureus 8325-4 derivative with a deletion in the RNAIII
region, while S. aureus V8, with a similar deletion in the
RNAIII region, still produced hla mRNA, albeit at a
10-fold-lower level than in the parent strain. It can be suggested that
in addition to RNAIII,
B also regulates hla
transcription indirectly. Whether SarA in combination with another
protein whose expression is
B dependent is involved in
toxin gene regulation in S. aureus remains an open question.
| |
ACKNOWLEDGMENTS |
|---|
We are grateful to W. Hendrickson and V. Kapatral for critical reading of the manuscript and constructive criticisms. The RNA polymerase used in this study was prepared by R. Deora during his graduate studies in this laboratory, and R. Fleming assisted in the construction of the pMP7-cna plasmid.
This work was supported by the Stephen W. and Alice A. Benedict Medical Research Fund administered by the University of Illinois at Chicago.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Microbiology and Immunology (M/C 790), University of Illinois College of Medicine, 835 South Wolcott Ave., Chicago, IL 60612-7344. Phone: (312) 996-9609. Fax: (312) 996-6415. E-mail: tmisra{at}uic.edu.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Bayer, M. G.,
J. H. Heinrichs, and A. L. Cheung.
1996.
The molecular architecture of the sar locus in Staphylococcus aureus.
J. Bacteriol.
178:4563-4570 |
| 2. | Betley, M. J., T. M. Soltis, and J. L. Couch. 1990. Molecular biological analysis of staphylococcal toxins, p. 327-342. In R. P. Novick (ed.), Molecular biology of the staphylococci. VCH Publishers, New York, N.Y. |
| 3. | Blevins, J. S., A. F. Gillaspy, T. M. Rechtin, B. K. Hulburt, and M. S. Smeltzer. 1999. The staphylococcal accessory regulator (sar) represses transcription of the Staphylococcus aureus collagen adhesion gene (cna) in an agr-independent manner. Mol. Microbiol. 33:317-326[CrossRef][Medline]. |
| 4. |
Borst, D. W., and M. J. Betley.
1994.
Promoter analysis of the staphylococcal enterotoxin A gene.
J. Biol. Chem.
269:1883-1888 |
| 5. |
Chan, P. F., and S. J. Foster.
1998.
Role of SarA in virulence determinant production and environmental signal transduction in Staphylococcus aureus.
J. Bacteriol.
180:6232-6241 |
| 6. |
Cheung, A. L.,
M. G. Bayer, and J. H. Heinrichs.
1997.
sar genetic determinants necessary for transcription of RNAII and RNAIII in the agr locus of Staphylococcus aureus.
J. Bacteriol.
179:3963-3971 |
| 7. | Cheung, A. L., K. Eberhardt, and J. H. Heinrichs. 1997. Regulation of protein A synthesis by the sar and agr loci of Staphylococcus aureus. Infect. Immun. 65:2243-2249[Abstract]. |
| 8. |
Cheung, A. L.,
M. J. Koomey,
C. A. Butler,
S. J. Projan, and V. A. Fischetti.
1992.
Regulation of exoprotein gene expression in Staphylococcus aureus by a locus (sar) distinct from agr.
Proc. Natl. Acad. Sci. USA
89:6462-6466 |
| 9. |
Chien, Y.-T., and A. L. Cheung.
1998.
Molecular interactions between two global regulators: sar and agr, in Staphylococcus aureus.
J. Biol. Chem.
273:2645-2652 |
| 10. | Chien, Y.-T., A. Manna, and A. L. Cheung. 1998. SarA level is a determinant of agr activation in Staphylococcus aureus. Mol. Microbiol. 30:991-1001[CrossRef][Medline]. |
| 11. |
Chien, Y.-T.,
A. Manna,
S. Projan, and A. L. Cheung.
1999.
SarA, a global regulator of virulence determinants in Staphylococcus aureus, binds to a conserved motif essential for sar-dependent gene regulation.
J. Biol. Chem.
274:37169-37176 |
| 12. |
Chugani, S. A.,
M. R. Parsek,
C. D. Hershberger,
K. Murakami,
A. Ishihama, and A. M. Chakrabarty.
1997.
Activation of the catBCA promoter: probing the interaction of CatR and RNA polymerase through in vitro transcription.
J. Bacteriol.
179:2221-2227 |
| 13. |
Czop, J. K., and M. S. Bergdoll.
1974.
Staphylococcal enterotoxin synthesis during the exponential, transitional, and stationary growth phases.
Infect. Immun.
9:229-235 |
| 14. |
Deora, R., and T. K. Misra.
1996.
Characterization of the primary factor of Staphylococcus aureus.
J. Biol. Chem.
271:21828-21834 |
| 15. |
Deora, R.,
T. Tseng, and T. K. Misra.
1997.
Alternative transcription factor SB of Staphylococcus aureus: characterization and role in transcription of the global regulatory locus sar.
J. Bacteriol.
179:6355-6359 |
| 16. | Duthie, E. S., and L. L. Lorenz. 1952. Staphylococcal coagulase: mode of action and antigenicity. J. Gen. Microbiol. 6:95-107[Medline]. |
| 17. |
Heinrichs, J. H.,
M. G. Bayer, and A. L. Cheung.
1996.
Characterization of the sar locus and its interaction with agr in Staphylococcus aureus.
J. Bacteriol.
178:418-423 |
| 18. |
Ji, G.,
R. C. Beavis, and R. P. Novick.
1995.
Cell density control of staphylococcal virulence mediated by an octapeptide pheromone.
Proc. Natl. Acad. Sci. USA
92:12055-12059 |
| 19. |
Ji, G.,
R. Beavis, and R. P. Novick.
1997.
A novel type of bacterial interference caused by a hypervariable autoinducing peptide.
Science
276:2027-2030 |
| 20. | Kornblum, J. B., B. N. Kreiswirth, S. J. Projan, H. Ross, and R. P. Novick. 1990. agr: a polycistronic locus regulating exoprotein synthesis in Staphylococcus aureus, p. 373-402. In R. P. Novick (ed.), Molecular biology of the staphylococci. VCH Publishers, New York, N.Y. |
| 21. |
Kullik, I.,
P. Giachino, and T. Fuchs.
1998.
Deletion of the alternative sigma factor B in Staphylococcus aureus reveals its function as a global regulator of virulence genes.
J. Bacteriol.
180:4814-4820 |
| 22. | Lina, G., S. Jarrud, G. Ji, T. Greenland, A. Pedraza, J. Etienne, R. P. Novick, and F. Vandenesch. 1998. Transmembrane topology and histidine protein kinase activity of AgrC, the agr signal receptor in Staphylococcus aureus. Mol. Microbiol. 28:655-662[CrossRef][Medline]. |
| 23. | Lindsay, J. A., and S. J. Foster. 1999. Interactive regulatory pathways control virulence determinant production and stability in response to environmental conditions in Staphylococcus aureus. Mol. Gen. Genet. 262:323-331[CrossRef][Medline]. |
| 24. |
Manna, A. C.,
M. G. Bayer, and A. L. Cheung.
1998.
Transcriptional analysis of different promoters in the sar locus in Staphylococcus aureus.
J. Bacteriol.
180:3828-3836 |
| 25. |
Miyazaki, E.,
J.-M. Chen,
C. Ko, and W. R. Bishai.
1999.
The Staphylococcus aureus rsbW (orf159) gene encodes an anti-sigma factor of SigB.
J. Bacteriol.
181:2846-2851 |
| 26. | Morfeldt, E., A. Janzon, A. von Gabin, S. Arvidson, and S. Lofdahl. 1988. Cloning of a chromosomal locus (exp) which regulates the expression of several exoprotein genes in Staphylococcus aureus. Mol. Gen. Genet. 211:435-440[CrossRef][Medline]. |
| 27. | Morfeldt, E., D. Taylor, A. von Gabin, and S. Arvidson. 1995. Activation of alpha toxin in Staphylococcus aureus by the trans-encoded antisense RNA, RNAIII. EMBO J. 14:4569-4577[Medline]. |
| 28. | Morfeldt, E., K. Tegmark, and S. Arvidson. 1996. Transcriptional control of the agr-dependent virulence gene regulator, RNAIII, in Staphylococcus aureus. Mol. Microbiol. 21:1227-1237[CrossRef][Medline]. |
| 29. | Novick, R. P., H. F. Ross, S. J. Projan, J. Kornblum, B. Kreiswirth, and S. Moghazeh. 1993. Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule. EMBO J. 12:3967-3975[Medline]. |
| 30. |
Otero, A.,
M. L. García,
M. C. García,
B. Moreno, and M. S. Bergdoll.
1990.
Production of staphylococcal enterotoxins C1 and C2 and thermonuclease throughout the growth cycle.
Appl. Environ. Microbiol.
56:555-559 |
| 31. |
Peng, H.-L.,
R. P. Novick,
B. Kreiswirth,
J. Kornblum, and P. Schlievert.
1988.
Cloning, characterization, and sequencing of an accessory gene regulator (agr) in Staphylococcus aureus.
J. Bacteriol.
170:4365-4372 |
| 32. |
Rao, L.,
R. K. Karls, and M. J. Betley.
1995.
In vitro transcription of pathogenesis-related genes by purified RNA polymerase from Staphylococcus aureus.
J. Bacteriol.
177:2609-2614 |
| 33. | Rechtin, T. M., A. F. Gillaspy, M. A. Schumacher, R. G. Brennan, M. S. Smeltzer, and B. K. Hulburt. 1999. Characterization of the SarA virulence gene regulator of Staphylococcus aureus. Mol. Microbiol. 33:307-316[CrossRef][Medline]. |
| 34. | Recsei, P. R., B. Kreiswirth, M. O'Reilly, P. Schlievert, A. Gruss, and R. P. Novick. 1986. Regulation of exoprotein gene expression in Staphylococcus aureus by agr. Mol. Gen. Genet. 202:58-61[CrossRef][Medline]. |
| 35. |
Regassa, L. B.,
J. L. Couch, and M. J. Betley.
1991.
Steady-state staphylococcal enterotoxin type C mRNA is affected by a product of the accessory gene regulator (agr) and by glucose.
Infect. Immun.
59:955-962 |
| 36. |
Saravia-Otten, P.,
H.-P. Müller, and S. Arvidson.
1997.
Transcription of Staphylococcus aureus fibronectin binding protein genes is negatively regulated by agr and an agr-independent mechanism.
J. Bacteriol.
179:5259-5263 |
| 37. | Singh, V. K., A. Xiong, T. R. Usgaard, S. Chakrabarti, R. Deora, T. K. Misra, and R. K. Jayaswal. 1999. ZntR is an autoregulatory protein and negatively regulates the chromosomal zinc resistance operon znt of Staphylococcus aureus. Mol. Microbiol. 33:200-207[CrossRef][Medline]. |
| 38. | Tegmark, K., A. Karlson, and S. Arvidson. 2000. Identification and characterisation of SarH1, a new global regulator of virulence gene expression in Staphylococcus aureus. Mol. Microbiol. 37:398-409[CrossRef][Medline]. |
| 39. | Tremaine, M. T., D. K. Brockman, and M. J. Betley. 1993. Staphylococcal enterotoxin A gene (sea) expression is not affected by the accessory gene regulator (agr). Infect. Immun. 61:356-359. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Appl. Environ. Microbiol. | Infect. Immun. | Eukaryot. Cell |
|---|---|---|
| Mol. Cell. Biol. | J. Virol. | Microbiol. Mol. Biol. Rev. |
| ALL ASM JOURNALS |